Neural stem cell therapy in neurological diseases

Archives of Medical Science

Volumn 5, Issue 3, 2009, Pages 296-302

  Uyanikgil, Yigit ^a   Balcioglu, Huseyin Avni ^b  

^a EGE UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Migration; Neural stem cell; Neurodegenerative disease

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN TUMOR; CANCER STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE CELL PLASTICITY; NERVE GRAFT; NERVE REGENERATION; NEURAL STEM CELL TRANSPLANTATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; REVIEW; SPINAL CORD INJURY;

EID: 73449098921     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Ross JJ, Verfaillie CM. Evaluation of neural plasticity in adult stem cells. Philos Trans R Soc Lond B Biol Sci 2008; 363: 199-205.
2. Conti L, Cattaneo E, Papadimou E. Novel neural stem cell systems. Expert Opin Biol Ther 2008; 8: 153-60.
3. Zhang SC, Li XJ, Johnson MA, Pankratz MT. Human embryonic stem cells for brain repair? Philos Trans R Soc Lond B Biol Sci 2008; 363: 87-99.
4. Yadirgi G, Marino S. Adult neural stem cells and their role in brain pathology. J Pathol 2009; 217: 242-53.
5. Torrente Y, Polli E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant 2008; 17: 1103-13.
6. Vaquero J, Zurita M. Bone marrow stromal cells for spinal cord repair: a challenge for contemporary neurobiology. Histol Histopathol 2009; 24: 107-16.
7. Zheng T, Marshall GP 2nd, Chen KA, Laywell ED. Transplantation of neural stem/progenitor cells into developing and adult CNS. Methods Mol Biol 2009; 482: 185-97.
8. Li T, Jiang L, Zhang X, Chen H. In-vitro effects of brain-derived neurotrophic factor on neural progenitor/stem cells from rat hippocampus. Neuroreport 2009; 20: 295-300.
9. Akesson E, Sandelin M, Kanaykina N, Aldskogius H, Kozlova EN. Long-term survival, robust neuronal differentiation, and extensive migration of human forebrain stem/progenitor cells transplanted to the adult rat dorsal root ganglion cavity. Cell Transplant 2008; 17: 1115-23.
10. Jolly LA, Taylor V, Wood SA. USP9X Enhances the polarity and self-renewal of embryonic stem cell-derived neural progenitors. Mol Biol Cell 2009; 20: 2015-29.
11. Jagatha B, Divya MS, Sanalkumar R, et al. In vitro differentiation of retinal ganglion-like cells from embryonic stem cell derived neural progenitors. Biochem Biophys Res Commun 2009; 380: 230-5.
12. Zimmermann S, Martens UM. Telomeres, senescence, and hematopoietic stem cells. Cell Tissue Res 2008; 331: 79-90.
13. Verfaillie CM, Pera MF, Lansdorp PM. Stem cells: hype and reality. Hematology Am Soc Hematol Educ Program 2002; 1: 369-91.
14. Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000; 287: 1442-6.
15. Van der Kooy D, Weiss S. Why stem cells? Science 2000; 287: 1439-41.
16. Knoblich JA. Asymmetric cell division during animal development. Nat Rev Mol Cell Biol 2001; 2: 11-20.
17. Donovan PJ, Gearhart J. The end of the beginning for pluripotent stem cells. Nature 2001; 414: 92-7.
18. Cantz T, Manns MP, Ott M. Stem cells in liver regeneration and therapy. Cell Tissue Res 2008; 331: 271-82.
19. Svendsen CN, Rosser AE. Neurones from stem cells? Trends Neurosci 1995; 18: 465-7.
20. McLaren FH, Svendsen CN, Van der Meide P, Joly E. Analysis of neural stem cells by flow cytometry: Cellular differentiation modifies patterns of MHC expression. J Neuroimmunol 2001; 112: 35-46.
21. Murayama A, Matsuzaki Y, Kawaguchi A, Shimazaki T, Okano H. Flow cytometric analysis of neural stem cells in the developing and adult mouse brain. J Neurosci Res 2002; 69: 837-47.
22. Hall PA, Watt FM. Stem cells: the generation and maintenance of cellular diversity. Development 1989; 106: 619-33.
23. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990; 110: 1001-20.
24. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004; 116: 639-48.
25. Greco B, Recht L. Somatic plasticity of neural stem cells: fact or fancy? J Cell Biochem 2003; 88: 51-6.
26. Garcia-Verdugo JM, Doetsch F, Wichterle H, Lim D, Alvarez-Buylla A. Architecture and cell types of the adult subventricular zone (SVZ): in search of the stem cells. J Neurobiol 1998; 36: 234-48.
27. Zhang RL, Zhang ZG, Zhang L, Chopp M. Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia. Neuroscience 2001; 105: 33-41.
28. Frisen J. Stem cell plasticity? Neuron 2002; 35: 415-8.
29. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999; 283: 534-7.
30. Bjorklund A, Svendsen CN. Chimeric stem cells. Trends Mol Med 2001; 7: 144-6.
31. Liu Y, Rao MS. Oligo genes are expressed in a heterogeneous population of precursor cells in the developing spinal cord. Glia 2004; 45: 67-74.
32. Alison MR, Poulsom R, Jeffery R, et al. Hepatocytes from non-hepatic adult stem cells. Nature 2000; 406: 257.
33. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168-70.
34. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 2001; 938: 221-9.
35. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279: 1528-30.
36. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999; 401: 390-4.
37. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000; 290: 1775-9.
38. Mezey E, Chandross KJ. Bone marrow: a possible alternative source of cells in the adult nervous system. Eur J Pharmacol 2000; 405: 297-302.
39. Overturf K, Al-Dhalimy M, Ou CN, Finegold M, Grompe M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997; 151: 1273-80.
40. McKinney-Freeman SL, Jackson KA, Camargo FD, Ferrari G, Mavilio F, Goodell MA. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci USA 2002; 99: 1341-6.
41. Hu E, Tontonoz P, Spiegelman BM. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci USA 1995; 92: 9856-60.
42. Toma JG, Akhavan M, Fernandes KJ, et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001; 3: 778-84.
43. Clarke DL, Johansson CB, Wilbertz J, et al. Generalized potential of adult neural stem cells. Science 2000; 288: 1660-3.
44. Galli R, Borello U, Gritti A, et al. Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 2000; 3: 986-91.
45. Clarke D, Frisen J. Differentiation potential of adult stem cells. Curr Opin Genet Dev 2001; 11: 575-80.
46. Tsai RY, McKay RD. Cell contact regulates fate choice by cortical stem cells. J Neurosci 2000; 20: 3725-35.
47. Buzańska L, Jurga M, Stachowiak EK, Stachowiak MK, Domańska-Janik K. Neural stem-like cell line derived from a nonhematopoietic population of human umbilical cord blood. Stem Cells Dev 2006; 15: 391-406.
48. Hess DC, Borlongan CV. Stem cells and neurological diseases. Cell Prolif 2008; 41 Suppl 1: 94-114.
49. Féron F. Current cell therapy strategies for repairing the central nervous system [French]. Rev Neurol 2007; 163 Spec No 1: 3S23-30.
50. Ostenfeld T, Svendsen CN. Recent advances in stem cell neurobiology. Adv Tech Stand Neurosurg 2003; 28: 3-89.
51. Björklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci 2000; 3: 537-44.
52. Annett LE, Martel FL, Rogers DC, Ridley RM, Baker HF, Dunnett SB. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 1994; 125: 228-46.
53. Herman JP, Abrous ND. Dopaminergic neural grafts after fifteen years: results and perspectives. Prog Neurobiol 1994; 44: 1-35.
54. Olanow CW, Fahn S, Langston JW, Godbold J. Selegiline and mortality in Parkinson's disease. Ann Neurol 1996; 40: 841-5.
55. Piccini P, Brooks DJ, Björklund A, et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 1999; 2: 1137-40.
56. Lindvall O. Clinical application of neuronal grafts in Parkinson's disease. J Neurol 1994; 242 (1 Suppl 1): S54-6.
57. Brasted PJ, Robbins TW, Dunnett SB. Distinct roles for striatal subregions in mediating response processing revealed by focal excitotoxic lesions. Behav Neurosci 1999; 113: 253-64.
58. Palfi S, Condé F, Riche D, et al. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat Med 1998; 4: 963-6.
59. Bachoud-Lévi AC, Rémy P, Nguyen JP, et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000; 356: 1975-9.
60. Philpott LM, Kopyov OV, Lee AJ, et al. Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations. Cell Transplant 1997; 6: 203-12.
61. Mazzini L, Fagioli F, Boccaletti R, et al. Stem cell therapy in amyotrophic lateral sclerosis: A methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 4: 158-61.
62. Deda H, Inci M, Kürekçi AE, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 2009; 11: 18-25.
63. Lindvall O, Kokaia Z. Recovery and rehabilitation in stroke: stem cells. Stroke 2004; 35 (11 Suppl 1): 2691-4.
64. Daadi MM, Steinberg GK. Manufacturing neurons from human embryonic stem cells: biological and regulatory aspects to develop a safe cellular product for stroke cell therapy. Regen Med 2009; 4: 251-63.
65. Arien-Zakay H, Lecht S, Bercu MM, et al. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp Neurol 2009; 216: 83-94.
66. Kozłowska H, Jabłonka J, Janowski M, Jurga M, Kossut M, Domańska-Janik K. Transplantation of a novel human cord blood-derived neural-like stem cell line in a rat model of cortical infarct. Stem Cells Dev 2007; 16: 481-8.
67. Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009; 6: e1000029.
68. Lytle JM, Wrathall JR. Glial cell loss, proliferation and replacement in the contused murine spinal cord. Eur J Neurosci 2007; 25: 1711-24.
69. Mothe AJ, Kulbatski I, Parr A, Mohareb M, Tator CH. Adult spinal cord stem/progenitor cells transplanted as neurospheres preferentially differentiate into oligodendrocytes in the adult rat spinal cord. Cell Transplant 2008; 17: 735-51.
70. Parr AM, Kulbatski I, Tator CH. Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury. J Neurotrauma 2007; 24: 835-45.
71. Neuhuber B, Barshinger AL, Paul C, Shumsky JS, Mitsui T, Fischer I. Stem cell delivery by lumbar puncture as a therapeutic alternative to direct injection into injured spinal cord. J Neurosurg Spine 2008; 9: 390-9.
72. Zurita M, Vaquero J. Functional recovery in chronic paraplegia after bone marrow stromal cells transplantation. Neuroreport 2004; 15: 1105-8.
73. Sykova E, Jendelova P, Glogarova K, Urzilova L, Herynek V, Hajek M. Bone marrow stromal cells - a promising tool for therapy of brain and spinal cord injury. Exp Neurol 2004; 187: 220.
74. Schalow G. Stem cell therapy and coordination dynamics therapy to improve spinal cord injury. Electromyogr Clin Neurophysiol 2008; 48: 233-53.
75. Pluchino S, Quattrini A, Brambilla E, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003; 422: 688-94.
76. Shihabuddin LS, Palmer TD, Gage FH. The search for neural progenitor cells: prospects for the therapy of neurodegenerative disease. Mol Med Today 1999; 5: 474-80.
77. Dahlstrand J, Collins VP, Lendahl U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 1992; 52: 5334-41.
78. Valtz NL, Hayes TE, Norregaard T, Liu SM, McKay RD. An embryonic origin for medulloblastoma. New Biol 1991; 3: 364-71.
79. Tsai RY, McKay RD. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 2002; 16: 2991-3003.
80. Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97: 12846-51.
81. Rosser AE, Zietlow R, Dunnett SB. Stem cell transplantation for neurodegenerative diseases. Curr Opin Neurol 2007; 20: 688-92.
82. Wang YX, Lam WW. Characterisation of brain disorders and evaluation of therapy by functional and molecular magnetic resonance techniques. Hong Kong Med J 2008; 14: 469-78.
83. Schaller BJ, Modo M, Buchfelder M. Molecular imaging of brain tumors: a bridge between clinical and molecular medicine? Mol Imaging Biol 2007; 9: 60-71.
84. Ehtesham M, Kabos P, Gutierrez MA, et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2002; 62: 7170-4.
85. Lee da Y, Gutmann DH. Cancer stem cells and brain tumors: uprooting the bad seeds. Expert Rev Anticancer Ther 2007; 7: 1581-90.
86. Lebelt A, Szkudlarek M, Guzińska-Ustymowicz K, Lemancewicz D, Zimnoch L, Dziecioł J. Proliferative activity of chosen central nervous system (CNS) neoplasms. Rocz Akad Med Bialymst 2004; 49 Suppl 1: 242-3.
87. Sakariassen PØ, Immervoll H, Chekenya M. Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia 2007; 9: 882-92.